SPL84 is administered directly into the lungs where it is taken up by the cells and is expected to drive the production of fully functional CFTR proteins. The Food and Drug Administration (FDA) has ...

First-in-human Phase 1 study in 56 healthy participants demonstrated KIT2014’s safety and tolerability KIT2014 is being developed as an inhalation therapy for respiratory diseases including chronic ...

A new study from North Carolina State University shows that lung stem cell secretions - specifically exosomes and secretomes - delivered via nebulizer, can help repair lung injuries due to multiple ...

NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB to develop a new inhaled treatment aimed at ...

A Korean woman is at a medical consultation. She has asthma and her doctor is holding a puffer. The patient is listening intently as the doctor explains how to use the device correctly. The two are ...